(Q35837657)

10 August 2017

1 reference

title

AT(1)-receptor blockade and sympathetic neurotransmission in cardiovascular disease (English)

1 reference

10 August 2017

Nap A

1

1 reference

10 August 2017

Balt JC

series ordinal

2

1 reference

10 August 2017

Mathy MJ

series ordinal

3

1 reference

10 August 2017

Van Zwieten PA

series ordinal

4

1 reference

10 August 2017

publication date

1 October 2003

1 reference

Autonomic and Autacoid Pharmacology

10 August 2017

published in

1 reference

10 August 2017

volume

23

1 reference

10 August 2017

issue

5-6

1 reference

10 August 2017

page(s)

285-296

1 reference

Angiotensin II receptors in the human brain

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Angiotensin II binding in area postrema and nucleus tractus solitarius of SHR and WKY rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Inhibition of angiotensin II-induced facilitation of sympathetic neurotransmission in the pithed rat: a comparison between losartan, irbesartan, telmisartan, and captopril

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan and embusartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Sympathetic overactivity as a cause of hypertension in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Prejunctional and postjunctional inhibitory actions of eprosartan and candesartan in the isolated rabbit mesenteric artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Decreased facilitation by angiotensin II of noradrenergic neurotransmission in isolated mesenteric artery of rabbits with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Evidence for the involvement of different receptor subtypes in the pre- and postjunctional actions of angiotensin II at rat sympathetic neuroeffector sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Multiple prejunctional actions of angiotensin II on noradrenergic transmission in the caudal artery of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Comparison of the vascular and antiadrenergic activities of four angiotensin II type 1 antagonists in the pithed rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Adrenergic nervous system in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Interactions between angiotensin II and alpha-adrenoceptor agonists mediating pressor responses in the pithed rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Differential effects of eprosartan and losartan at prejunctional angiotensin II receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Presynaptic receptors and alterations in norepinephrine release in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

A novel effect of angiotensin on renal sympathetic nerve activity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Sympathetic activation in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Sympatholytic properties of several AT1-receptor antagonists in the isolated rabbit thoracic aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Pre- and postsynaptic inhibitory potencies of the angiotensin AT1 receptor antagonists eprosartan and candesartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Different AT1 receptor subtypes at pre- and postjunctional sites: AT1A versus AT1B receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Angiotensin II amplification of alpha-adrenergic vasoconstriction: role of receptor reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Angiotensin converting enzyme inhibition improves cardiac neuronal uptake of noradrenaline in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Effects of losartan and its combination with quinapril on the cardiac sympathetic nervous system and neurohormonal status in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Presynaptic receptor systems in catecholaminergic transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Effects of selective angiotensin II receptor blockade on sympathetic nerve activity in primary hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Plasma norepinephrine in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Role of sympathetic nervous system activity in the blood pressure response to long-term captopril therapy in severely hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

The renin-angiotensin-aldosterone system: a specific target for hypertension management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

Effect of blocking angiotensin II receptor subtype on rat sympathetic nerve function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-8673.2004.00301.X

10.1111/J.1474-8673.2004.00301.X

21 January 2018

Identifiers

DOI

1 reference

release_ijldrucgtbgetg5yfurxhhyr2m

10 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ijldrucgtbgetg5yfurxhhyr2m

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference